3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
12
Carcinoma, Renal Cell
11
Lymphoma
3
Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Margins of Excision
1
Kidney Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
HTLV-I Infections
1
Carcinoma
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Adenocarcinoma
1
Interventions
fludarabine phosphate
19
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
15
Mycophenolic Acid
15
Tacrolimus
12
Cyclophosphamide
11
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Methotrexate
8
Rituximab
7
Etoposide
6
Melphalan
5
Flow Cytometry
5
pembrolizumab
4
Radiotherapy
4
Panobinostat
4
Lenalidomide
4
Filgrastim
4
Everolimus
4
Dexamethasone
4
Calcium Dobesilate
4
Bexarotene
4
thymoglobulin
3
romidepsin
3
hypericin
3
fludarabine
3
Therapeutics
3
Sirolimus
3
In Situ Hybridization, Fluorescence
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mycosis Fungoides
×
Interferon alpha-2
×
Clear all
No trials found.